Health Canada approval for SpryngⓇ and the acquisition of PBM marked major milestones, while AI-driven platforms and strategic partnerships expanded market reach. Fiscal 2026 saw flat revenues, higher losses, and a declining cash position, but strong growth is anticipated in 2027.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.